Evidence map›Paper›PMID 29946443›Full record

ArticleF1000Research2018

Comparing protein structures with RINspector automation in Cytoscape.

Guillaume Brysbaert, Théo Mauri, Marc F Lensink

Abstract read
In one paragraph

Article in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Highlighted role of VEGFA in follow up of celiac disease.Gastroenterology and hepatology from bed to bench · 2019
    Article
  9. Evaluation of gene expression change in eosinophilic gastroenteritis.Gastroenterology and hepatology from bed to bench · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guillaume BrysbaertCNRS UMR 8576 UGSF, University of Lille, Lille, F-59000, France.ORCID https://orcid.org/0000-0002-6807-6621
Théo MauriCNRS UMR 8576 UGSF, University of Lille, Lille, F-59000, France.
Marc F LensinkCNRS UMR 8576 UGSF, University of Lille, Lille, F-59000, France.ORCID https://orcid.org/0000-0003-3957-9470

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Residue interaction networks (RINs) have been shown to be relevant representations of the tertiary or quaternary structures of proteins, in particular thanks to network centrality analyses. We recently developed the RINspector 1.0.0 Cytoscape app, which couples centrality analyses with backbone flexibility predictions. This combined approach permits the identification of crucial residues for the folding or function of the protein that can constitute good targets for mutagenesis experiments. Here we present an application programming interface (API) for RINspector 1.1.0 that enables interplay between Cytoscape, RINspector and external languages, such as R or Python. This API provides easy access to batch centrality calculations and flexibility predictions, and allows for the easy comparison of results between different structures. These comparisons can lead to the identification of specific and conserved central residues, and show the impact of mutations to these and other residues on the flexibility of the proteins. We give two use cases to demonstrate the interest of these functionalities and provide the corresponding scripts: the first concerns NMR conformers, the second focuses on mutations in a structure.

Indexed as

automationcentrality analysiscytoscapeflexibility predictionprotein structureresidue interaction networkrinspectorstructure ensemble

Identifiers

PMID29946443
PMCPMC5998007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.